SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 69 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $204,000 | -85.0% | 211,820 | -81.4% | 0.00% | – |
| Q1 2022 | $1,356,000 | -63.8% | 1,139,351 | -0.8% | 0.00% | – |
| Q4 2021 | $3,746,000 | -24.9% | 1,148,939 | +3.0% | 0.00% | – |
| Q3 2021 | $4,987,000 | -8.4% | 1,115,572 | +11.6% | 0.00% | – |
| Q2 2021 | $5,446,000 | -8.5% | 999,254 | +25.6% | 0.00% | – |
| Q1 2021 | $5,949,000 | -24.6% | 795,345 | +9.4% | 0.00% | – |
| Q4 2020 | $7,887,000 | -47.5% | 726,939 | -57.2% | 0.00% | -100.0% |
| Q3 2020 | $15,023,000 | +66.8% | 1,699,482 | +101.1% | 0.00% | 0.0% |
| Q2 2020 | $9,009,000 | +132.6% | 845,149 | +29.4% | 0.00% | – |
| Q1 2020 | $3,873,000 | -17.9% | 653,131 | -4.4% | 0.00% | – |
| Q4 2019 | $4,719,000 | -32.6% | 682,962 | +1.3% | 0.00% | -100.0% |
| Q3 2019 | $6,999,000 | +34.2% | 674,261 | +19.7% | 0.00% | – |
| Q2 2019 | $5,216,000 | +35.6% | 563,332 | +33.8% | 0.00% | – |
| Q1 2019 | $3,847,000 | +68.4% | 420,892 | +2.6% | 0.00% | – |
| Q4 2018 | $2,284,000 | -49.8% | 410,119 | +7.4% | 0.00% | – |
| Q3 2018 | $4,550,000 | +26.8% | 381,882 | +8.6% | 0.00% | – |
| Q2 2018 | $3,589,000 | +37.1% | 351,767 | +74.4% | 0.00% | – |
| Q1 2018 | $2,618,000 | +41.0% | 201,742 | +5.8% | 0.00% | – |
| Q4 2017 | $1,857,000 | -34.4% | 190,643 | -0.9% | 0.00% | – |
| Q3 2017 | $2,832,000 | +3.8% | 192,436 | +13.5% | 0.00% | – |
| Q2 2017 | $2,728,000 | +179.5% | 169,497 | +176.7% | 0.00% | – |
| Q1 2017 | $976,000 | +76.2% | 61,247 | +34.8% | 0.00% | – |
| Q4 2016 | $554,000 | +59.7% | 45,447 | +81.9% | 0.00% | – |
| Q3 2016 | $347,000 | – | 24,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |